<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02213380</url>
  </required_header>
  <id_info>
    <org_study_id>RAGA-Delirium</org_study_id>
    <nct_id>NCT02213380</nct_id>
  </id_info>
  <brief_title>Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery</brief_title>
  <acronym>RAGADelirium</acronym>
  <official_title>Effect of Regional Anaesthesia and General Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery: a Multicenter Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Institute for Family Planning, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate postoperative delirium after general anesthesia and
      regional anesthesia in elderly patients undergoing hip fracture surgery. Our research
      hypotheses are: (1) regional anesthesia may contribute to decrease the incidence of
      postoperative delirium. (2) Regional anesthesia may improve the outcome of elderly patient
      and reduce healthcare costs associated with postoperative delirium. (3) Postoperative
      delirium may result in poor long-term functional outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative delirium (POD) is an acute confusional state associated with changes in
      consciousness, arousal level and cognitive status. Elderly patients with hip fractures have
      the high incidence of delirium. The high risk factor of delirium include: Age 65 years or
      older, cognitive impairment/dementia, current hip fracture, severe illness and so on. Many
      previous studies predict that the majority of general anesthetic and sedative agents can
      favour postoperative delirium. However, none of studies have investigated the effect of
      general anesthesia and the effect of regional anesthesia and general anesthesia on the
      postoperative delirium in elderly patients undergoing hip fracture surgery in China. This
      multicentre, prospective, randomized controlled clinical trial is designed to evaluate
      postoperative delirium after general anesthesia and regional anesthesia in elderly patients
      undergoing hip fracture surgery. Our research hypotheses are: (1) regional anesthesia may
      contribute to decrease the incidence of postoperative delirium. (2) Regional anesthesia may
      improve the outcome of elderly patient and reduce healthcare costs associated with
      postoperative delirium. (3) Postoperative delirium may result in poor long-term functional
      outcomes.

      This trial has the following nine investigational centers: Department of Anesthesiology, The
      Second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University, Wenzhou,
      China; Department of Anesthesiology, Tongji Hospital, Tongji Medical college, Huazhong
      University of Science &amp; Technology, Wuhan, China; Department of Anesthesiology, West China
      Hospital of Sichuan University, Chengdu, China; Department of Anesthesiology, Southwest
      Hospital, Chongqing, China; Department of Anesthesiology, The Second Affiliated Hospital of
      Zhejiang University School of Medicine, Hangzhou, China; Department of Anesthesiology,
      Beijing Jishuitan Hospital, Beijing, China; Department of Anesthesiology, The First
      Affiliated Hospital of Nanchang University, Nanchang, China; Department of Anesthesiology,
      The Second Hospital of Anhui Medical University, Anhui, China; The First Affiliated Hospital
      of Wenzhou Medical University, Wenzhou, China;

      Eligible patients will be assigned into two study groups (group RA: regional anesthesia will
      be used, group GA: General anesthesia will be used) by centre-minimization randomization (web
      or telephone). There are 3 stratification factors: age (65-79,≥80), presence of delirium(yes,
      no), dementia(yes, no). There will be two teams of investigators involved in trial procedure
      and the patient's follow-up. Investigator A (experienced anesthetist), who are competent in
      caring for patients undergoing hip fracture surgery, will perform following works, which
      includes informed consent, randomization, anesthesia and recovery parameters. Investigator B
      will visit patient the day before surgery and 7days after surgery or until discharge to
      assess patient for presence, type and severity of delirium, collect other data during in
      hospital stay and follow up patients at 6 and 12 months. Investigator B will receive uniform
      training of using of CAM, Delirium Rating Scale-Revised-98 (DRS-R-98), MMSE and other test
      used in this trial) and will be not clear about protocol.

      Within 24 h before surgery, cognitive function of each patient will be assessed with the
      MMSE, the presence of delirium will be diagnosed with the CAM, the type and severity of
      delirium will be assessed with DRS-R-98 and the pain will be assessed with a 100-mm visual
      analog scale (VAS). Routine monitoring (NBP, continuous ECG, and pulse oximetry) was
      initiated on all patients. Premedication for anesthesia will be avoided before surgery. Any
      medication impairing cognitive function will not be recommended, if administered, must be
      recorded it in detail.

      Investigator A will allocated the patient into group GA or group RA according the
      centre-randomization with a unique registration number for each eligible patient. Treatment
      protocols for both groups will also stipulate no sedative be administrated during operation.
      Routine monitoring was initiated on all patients. Hypotension (Systolic Blood Pressure&lt;90mmHg
      or drop of Mean Arterial Pressure&gt;30%) should be treated with vasoactive agents or fluid
      boluses as deemed appropriate by anesthetists.

      Postoperative analgesia will be administered according to the local procedures of each
      clinical trial site, aiming to maintain a VAS pain score ≤ 30 mm. Both groups will receive
      routine postoperative care on orthopedic ward.

      All randomized patients will be followed up to 7 days after surgery (or discharge from the
      hospital). The 7 days follow-up includes: CAM, DRS-98-R (if applicable), VAS, Analgesic use
      (if applicable), Sedative use (if applicable), Post-operative morbidity and laboratory
      results (including serum hemoglobin, hematocrit, leucocytes, aspartate aminotransferase
      (AST), alanine aminotransferase (ALT), albumin, serum creatinine and urea concentrations,
      serum sodium and potassium and serum glucose concentration). Concomitant medications, adverse
      events and serious adverse events are record in all study visits. Economic parameters
      include: time to be discharged from post operation, total cost in hospital and cost for
      anesthesia of patient. Investigator B will also assess patient with POD in clinic or at their
      residence at 6 and 12 months to assess for presence of delirium, its type and severity (CAM,
      DRS-98-R), cognitive function using MMSE, and quality of life using The MOS 36-item
      Short-Form Health Survey (SF-36) questionnaire.

      The study will be monitored regularly by the clinical research associate (CRA) through visits
      or telephone. CRA will verify the consistency of the data recorded on the case report forms
      with the source documents and the management of therapeutic batches, the presence and
      completeness of the investigator file.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Data collectors or outcome assessors, e.g. the medical staff who provide post-operative care in the ward and visit patients for preoperational assessment, hospital visits and subsequent follow-ups, will be blinded from group allocation throughout the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of POD in 7 days post operation</measure>
    <time_frame>in 7 days post operation</time_frame>
    <description>POD diagnosed with Confusion Assessment Method(CAM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The type of delirium diagnosed in 7 days post operation</measure>
    <time_frame>in 7 days post operation</time_frame>
    <description>The type of delirium diagnosed with the Delirium Rating Scale-Revised-98 (DRS-R-98)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute pain score using visual analogue scale (VAS)</measure>
    <time_frame>In 7days post operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative morbidity</measure>
    <time_frame>up to hospital discharge or death post operation</time_frame>
    <description>including chest infection, myocardial infarction, renal failure, gastrointestinal ileus and so on.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>on the day of discharge from hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>severity of delirium</measure>
    <time_frame>in 7days post operation</time_frame>
    <description>severity of delirium was diagnosed with the DRS-R-98</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of delirium</measure>
    <time_frame>in 7days post operation</time_frame>
    <description>diagnosed with CAM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day mortality</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months incidence of delirium</measure>
    <time_frame>6 months after discharge</time_frame>
    <description>in clinic or at their residence, diagnosed with CAM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12 months incidence of delirium</measure>
    <time_frame>12 months after discharge</time_frame>
    <description>in clinic or at their residence, diagnosed with CAM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months quality of life</measure>
    <time_frame>6 months after discharge</time_frame>
    <description>using SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12 months quality of life</measure>
    <time_frame>12months after discharge</time_frame>
    <description>using SF-36 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Post Operative Delirium</condition>
  <arm_group>
    <arm_group_label>group GA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Method of anesthesia: general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group RA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Method of anesthesia: regional anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>method of anesthesia</intervention_name>
    <description>Method of anesthesia includes: general anesthesia and regional anesthesia.
General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA.
Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA</description>
    <arm_group_label>group GA</arm_group_label>
    <arm_group_label>group RA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older patient (≥65 years)

          -  patient with hip fracture and planned hip fracture surgery

          -  patient willing to complete this study.

        Exclusion Criteria:

          -  patient with multiple trauma or multiple fractures, pathological fractures, pelvic
             fractures, femur fractures

          -  contraindication (serious illness or medical conditions) for general anesthesia

          -  contraindication (infection at the site of needle insertion, coagulopathy,
             international normalized ratio &gt;1.4, platelet count &lt;80×109 litre-1, allergy to local
             anaesthetics and so on) for regional anesthesia;

          -  patient who cannot complete the preoperative mental tests (CAM and/or Mini-Mental
             State Examination (MMSE)) of this clinical trial

          -  patient known to susceptible to malignant hyperthermia

          -  known allergy or hypersensitivity to any drugs administered during this clinical trial

          -  previous participation in this clinical trial

          -  participation in another clinical trial within 4 weeks prior to selection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fang Gao, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>The Second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qingquan Lian, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>The Second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Li, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>The Second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ting Li, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joice Yeung, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>HEART of ENGLAND NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teresa Moledy</last_name>
    <role>Study Director</role>
    <affiliation>HEART of ENGLAND NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ting LI, M.D.</last_name>
    <phone>00447570150148</phone>
    <email>liting1021@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sishi Chen</last_name>
    <phone>008613957753282</phone>
    <email>chensishiwz@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Second Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230601</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lijun Weng, M.D.</last_name>
      <phone>008613866774426</phone>
      <email>13866774426@126.com</email>
    </contact>
    <investigator>
      <last_name>Ye Zhang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical college</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuke Tian, M.D.</last_name>
      <phone>008613006162508</phone>
      <email>yktian@tjh.tjmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Wei Mei, M.D.</last_name>
      <phone>008613006162508</phone>
      <email>wmei@hust.edu.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Yuke Tian, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Mei, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoping Zhu, M.D.</last_name>
      <phone>008613907915506</phone>
      <email>13907915506@163.com</email>
    </contact>
    <investigator>
      <last_name>Fuquan Luo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanjun Lin, M.D.</last_name>
      <phone>008618980601624</phone>
      <email>18980601624@163.com</email>
    </contact>
    <investigator>
      <last_name>Ren Liao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ping Gao, M.D.</last_name>
      <phone>13958127671</phone>
      <email>gaoping1999@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Min Yan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Lishi</name>
      <address>
        <city>Lishi</city>
        <state>Zhejiang</state>
        <zip>323000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LiHua Fang</last_name>
      <phone>008618957090898</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Lishui City</name>
      <address>
        <city>Lishui</city>
        <state>Zhejiang</state>
        <zip>323000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LIPEI LEI</last_name>
      <phone>008613905883848</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo No.2 Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <zip>315010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GUORONG WU, M.D.</last_name>
      <phone>13600628721</phone>
      <email>13600628721@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo No.6 Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <zip>315040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GUORONG WU</last_name>
      <phone>008613600628721</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taizhou Hospital of Zhejiang Province</name>
      <address>
        <city>Taizhou</city>
        <state>Zhejiang</state>
        <zip>317000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MINGCANG WANG</last_name>
      <phone>008613757616856</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuzhong Xu, M.D.</last_name>
      <phone>008613706657799</phone>
      <email>xuzhong@263.net</email>
    </contact>
    <investigator>
      <last_name>Xuzhong Xu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Jishuitan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bingxue Liu, M.D.</last_name>
      <phone>13661188006</phone>
      <email>snowdon@sohu.com</email>
    </contact>
    <investigator>
      <last_name>Geng Wang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ting Zhao, M.D.</last_name>
      <phone>13983956536</phone>
      <email>273691504@qq.com</email>
    </contact>
    <investigator>
      <last_name>Kaizhi Lu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.wzhealth.com</url>
    <description>The second Affiliated Hospital &amp; Yuying Children hospital of Wenzhou Medical University</description>
  </link>
  <reference>
    <citation>Sanders RD, Pandharipande PP, Davidson AJ, Ma D, Maze M. Anticipating and managing postoperative delirium and cognitive decline in adults. BMJ. 2011 Jul 20;343:d4331. doi: 10.1136/bmj.d4331. Review.</citation>
    <PMID>21775401</PMID>
  </reference>
  <reference>
    <citation>Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc. 2001 May;49(5):516-22.</citation>
    <PMID>11380742</PMID>
  </reference>
  <reference>
    <citation>Bruce AJ, Ritchie CW, Blizard R, Lai R, Raven P. The incidence of delirium associated with orthopedic surgery: a meta-analytic review. Int Psychogeriatr. 2007 Apr;19(2):197-214. Epub 2006 Sep 14. Review.</citation>
    <PMID>16973101</PMID>
  </reference>
  <reference>
    <citation>Furlaneto ME, Garcez-Leme LE. Delirium in elderly individuals with hip fracture: causes, incidence, prevalence, and risk factors. Clinics (Sao Paulo). 2006 Feb;61(1):35-40. Epub 2006 Mar 10.</citation>
    <PMID>16532223</PMID>
  </reference>
  <reference>
    <citation>Nie H, Zhao B, Zhang YQ, Jiang YH, Yang YX. Pain and cognitive dysfunction are the risk factors of delirium in elderly hip fracture Chinese patients. Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):e172-4. doi: 10.1016/j.archger.2011.09.012. Epub 2011 Oct 19.</citation>
    <PMID>22014763</PMID>
  </reference>
  <reference>
    <citation>Eeles EM, Hubbard RE, White SV, O'Mahony MS, Savva GM, Bayer AJ. Hospital use, institutionalisation and mortality associated with delirium. Age Ageing. 2010 Jul;39(4):470-5. doi: 10.1093/ageing/afq052.</citation>
    <PMID>20554540</PMID>
  </reference>
  <reference>
    <citation>Zakriya K, Sieber FE, Christmas C, Wenz JF Sr, Franckowiak S. Brief postoperative delirium in hip fracture patients affects functional outcome at three months. Anesth Analg. 2004 Jun;98(6):1798-802, table of contents.</citation>
    <PMID>15155351</PMID>
  </reference>
  <reference>
    <citation>Kat MG, Vreeswijk R, de Jonghe JF, van der Ploeg T, van Gool WA, Eikelenboom P, Kalisvaart KJ. Long-term cognitive outcome of delirium in elderly hip surgery patients. A prospective matched controlled study over two and a half years. Dement Geriatr Cogn Disord. 2008;26(1):1-8. doi: 10.1159/000140611. Epub 2008 Jul 9.</citation>
    <PMID>18562793</PMID>
  </reference>
  <reference>
    <citation>Kat MG, de Jonghe JF, Vreeswijk R, van der Ploeg T, van Gool WA, Eikelenboom P, Kalisvaart KJ. Mortality associated with delirium after hip-surgery: a 2-year follow-up study. Age Ageing. 2011 May;40(3):312-8. doi: 10.1093/ageing/afr014. Epub 2011 Mar 17.</citation>
    <PMID>21414946</PMID>
  </reference>
  <reference>
    <citation>Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL, Yang FM, Kiely DK, Inouye SK. Delirium accelerates cognitive decline in Alzheimer disease. Neurology. 2009 May 5;72(18):1570-5. doi: 10.1212/WNL.0b013e3181a4129a.</citation>
    <PMID>19414723</PMID>
  </reference>
  <reference>
    <citation>Witlox J, Slor CJ, Jansen RW, Kalisvaart KJ, van Stijn MF, Houdijk AP, Eikelenboom P, van Gool WA, de Jonghe JF. The neuropsychological sequelae of delirium in elderly patients with hip fracture three months after hospital discharge. Int Psychogeriatr. 2013 Sep;25(9):1521-31. doi: 10.1017/S1041610213000574. Epub 2013 May 7.</citation>
    <PMID>23651760</PMID>
  </reference>
  <reference>
    <citation>Cole MG. Persistent delirium in older hospital patients. Curr Opin Psychiatry. 2010 May;23(3):250-4. doi: 10.1097/YCO.0b013e32833861f6. Review.</citation>
    <PMID>20224406</PMID>
  </reference>
  <reference>
    <citation>Young J, Murthy L, Westby M, Akunne A, O'Mahony R; Guideline Development Group. Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ. 2010 Jul 28;341:c3704. doi: 10.1136/bmj.c3704.</citation>
    <PMID>20667955</PMID>
  </reference>
  <reference>
    <citation>Sanders RD. Hypothesis for the pathophysiology of delirium: role of baseline brain network connectivity and changes in inhibitory tone. Med Hypotheses. 2011 Jul;77(1):140-3. doi: 10.1016/j.mehy.2011.03.048. Epub 2011 Apr 16.</citation>
    <PMID>21498007</PMID>
  </reference>
  <reference>
    <citation>Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998 Mar 21;351(9106):857-61. Erratum in: Lancet 1998 Jun 6;351(9117):1742.</citation>
    <PMID>9525362</PMID>
  </reference>
  <reference>
    <citation>Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, Vila P, Jolles J, Papaioannou A, Abildstrom H, Silverstein JH, Bonal JA, Raeder J, Nielsen IK, Korttila K, Munoz L, Dodds C, Hanning CD, Moller JT; ISPOCD2(International Study of Postoperative Cognitive Dysfunction) Investigators. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. 2003 Mar;47(3):260-6.</citation>
    <PMID>12648190</PMID>
  </reference>
  <reference>
    <citation>Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, Mears SC. Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc. 2010 Jan;85(1):18-26. doi: 10.4065/mcp.2009.0469. Erratum in: Mayo Clin Proc. 2010 Apr;85(4):400. Dosage error in article text.</citation>
    <PMID>20042557</PMID>
  </reference>
  <reference>
    <citation>Abou-Setta AM, Beaupre LA, Rashiq S, Dryden DM, Hamm MP, Sadowski CA, Menon MR, Majumdar SR, Wilson DM, Karkhaneh M, Mousavi SS, Wong K, Tjosvold L, Jones CA. Comparative effectiveness of pain management interventions for hip fracture: a systematic review. Ann Intern Med. 2011 Aug 16;155(4):234-45. doi: 10.7326/0003-4819-155-4-201108160-00346.</citation>
    <PMID>21844549</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8.</citation>
    <PMID>2240918</PMID>
  </reference>
  <reference>
    <citation>Folstein MF, Folstein SE, McHugh PR. &quot;Mini-mental state&quot;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98.</citation>
    <PMID>1202204</PMID>
  </reference>
  <reference>
    <citation>Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. Erratum in: J Neuropsychiatry Clin Neurosci 2001 Summer;13(3):433.</citation>
    <PMID>11449030</PMID>
  </reference>
  <reference>
    <citation>Huang MC, Lee CH, Lai YC, Kao YF, Lin HY, Chen CH. Chinese version of the Delirium Rating Scale-Revised-98: reliability and validity. Compr Psychiatry. 2009 Jan-Feb;50(1):81-5. doi: 10.1016/j.comppsych.2008.05.011. Epub 2008 Aug 23.</citation>
    <PMID>19059519</PMID>
  </reference>
  <reference>
    <citation>McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994 Jan;32(1):40-66.</citation>
    <PMID>8277801</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2014</study_first_submitted>
  <study_first_submitted_qc>August 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2014</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Ting Li</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>general anesthesia</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>elderly patient</keyword>
  <keyword>hip fracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

